Coles N Anthony is a director of Regeneron Pharmaceuticals, Inc.
Person profile
Roles
Address
Parsippany, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
144
Cerevel Therapeutics Holdings, Inc.
10 May 24
4
Cerevel Therapeutics Holdings, Inc.
3 Apr 24
144
Cerevel Therapeutics Holdings, Inc.
1 Apr 24
4
Cerevel Therapeutics Holdings, Inc.
6 Mar 24
4
Cerevel Therapeutics Holdings, Inc.
4 Mar 24
144
Cerevel Therapeutics Holdings, Inc.
4 Mar 24
144
Cerevel Therapeutics Holdings, Inc.
29 Feb 24
4
Cerevel Therapeutics Holdings, Inc.
8 Feb 24
4
Cerevel Therapeutics Holdings, Inc.
4 Jan 24
4
REGENERON PHARMACEUTICALS, INC.
4 Jan 24
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | CERE Cerevel Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 42.3328 | 50,000 | 2.12 mm | 15,638 |
1 Apr 24 | CERE Cerevel Therapeutics | Common Stock | Option exercise | Acquire M | No | Yes | 3.5 | 50,000 | 175.00 k | 65,638 |
1 Apr 24 | CERE Cerevel Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 3.5 | 50,000 | 175.00 k | 2,302,417 |
29 Feb 24 | CERE Cerevel Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 41.1578 | 50,000 | 2.06 mm | 15,638 |
29 Feb 24 | CERE Cerevel Therapeutics | Common Stock | Option exercise | Acquire M | No | Yes | 3.5 | 50,000 | 175.00 k | 65,638 |
29 Feb 24 | CERE Cerevel Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 3.5 | 50,000 | 175.00 k | 2,402,417 |
7 Feb 24 | CERE Cerevel Therapeutics | Common Stock | Sell | Dispose S | No | No | 41.5441 | 2,506 | 104.11 k | 15,638 |
6 Feb 24 | CERE Cerevel Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 15,440 | 0.00 | 18,144 |
6 Feb 24 | CERE Cerevel Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 15,440 | 0.00 | 46,322 |
2 Jan 24 | REGN Regeneron Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 135 | 0.00 | 1,393 |